Enhancement and depression of the antibody response in mice caused by Corynebacterium parvum
Warr, G.W.; Sljivić, V.S.
Clinical and Experimental Immunology 17(3): 519-532
1974
ISSN/ISBN: 0009-9104 PMID: 4157122 Document Number: 79533
Document emailed within 1 workday
Related Documents
Dimitrov, N.V.; Denny, T.N.; Weisman, M.F.; Cameron, D.G. 1979: Effect of adriamycin and Corynebacterium parvum in tumor-bearing mice: modulation of response to sheep red blood cells Journal of the National Cancer Institute 63(2): 423-426Watson, S.R.; Sljivić, V.S. 1976: The role of macrophages in the adjuvant effect on antibody production of Corynebacterium parvum Clinical and Experimental Immunology 23(1): 149-153
Kirchner, H.; Chmielarczyk, W.; Storch, E.; Schindler, L. 1984: Antiviral effects of Corynebacterium parvum and its effect on the interferon system in mice Behring Institute Mitteilungen 74: 183-188
Kiya, K.; Toge, T.; Harada, K.; Uozumi, T.; Hattori, T. 1981: Effect of intracerebral administration of Corynebacterium parvum on the growth of brain tumors in mice Gan 72(3): 446-450
Barth, R.F.; Singla, O. 1977: Distribution of technetium-99m labeled Corynebacterium parvum in normal and tumor bearing mice Developments in Biological Standardization 38: 129-135
Soyka, L.F.; Hunt, W.G.; Knight, S.E.; Foster, R.S. 1976: Decreased liver and lung drug-metabolizing activity in mice treated with Corynebacterium parvum Cancer Research 36(12): 4425-4428
Budzyński, W. 1982: Studies on antitumor effect of corynebacterium parvum and pustulan on Lewis lung carcinoma in mice Archivum Immunologiae et Therapiae Experimentalis 30(5-6): 379-384
Tomecki, J.; Mara, M. 1987: The immunological activities of components isolated from Corynebacterium parvum in mice injected with polyoma tumor cells Neoplasma 34(1): 15-22
Xiao, Y.; Lu, Y.; Zhang, J.; Cao, J.; Huang, X. 1990: Inhibition of growth and metastases of lung carcinoma in C57BL/6 mice by Corynebacterium parvum and its antitumor mechanism Hua Xi Yi Ke da Xue Xue Bao 21(3): 318-321
Bast, R.C.; Knapp, R.C.; Mitchell, A.K.; Thurston, J.G.; Tucker, R.W.; Schlossman, S.F. 1979: Immunotherapy of a murine ovarian carcinoma with Corynebacterium parvum and specific heteroantiserum. I. Activation of peritoneal cells to mediate antibody-dependent cytotoxicity Journal of Immunology 123(5): 1945-1951
Chen, M.F.; Suzuki, H.; Yano, S. 1992: Induction of murine lymphokine-activated killer-like cells by Corynebacterium parvum (C. parvum) in vitro: lysis of tumor cells and macrophages by C. parvum-induced killer cells Anticancer Research 12(2): 451-456
Shibata, Y. 1989: Restoration of prostaglandin E2-producing splenic macrophages in 89Sr-treated mice with bone marrow from Corynebacterium parvum primed donors Regional Immunology 2(3): 169-175
Wellek, B.; Kessel, G.; Loos, M.; Hahn, H. 1977: Increase of phagocytic activity and new appearance of a C4b (guinea pig) recognizing capability in peritoneal macrophages from Corynebacterium parvum and thioglycollate-stimulated mice Monographs in Allergy 12: 105-110
Wolmark, N.; Fisher, B. 1974: The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in syngeneic tumor-bearing mice Cancer Research 34(11): 2869-2872
Fisher, B.; Gunduz, N. 1979: Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. X. Effect of treatment on tumor cell kinetics in mice Journal of the National Cancer Institute 62(6): 1545-1551
Chiorazzi, N.; Fox, D.A.; Katz, D.H. 1976: Hapten-specific IgE antibody responses in mice. VI. Selective enhancement of IgE antibody production by low doses of X-irradiation and by cyclophosphamide Journal of Immunology 117(5 Part 1): 1629-1637
Medenica, R.; Girard, J.P.; Maurice, P. 1977: Clinical trial with Corynebacterium parvum Developments in Biological Standardization 38: 483-485
Zola, H. 1975: Mitogenicity of Corynebacterium parvum for mouse lymphocytes Clinical and Experimental Immunology 22(3): 514-521
Gatenby, P.A.; Basten, A.; Tattersall, M.H.; Fox, R.M. 1980: Autoantibodies in cancer patients given Corynebacterium parvum/levamisole immunotherapy Lancet 1(8177): 1082
Karakousis, C.P.; Didolkar, M.S.; Han, T. 1981: Chemoimmunotherapy (DTIC and Corynebacterium parvum) for disseminated malignant melanoma Cancer Treatment Reports 65(9-10): 925-926